Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341)

Kaiwen Wang; Jiangfeng Zhao; Zhiwei Chen; Ting Li; Xiaoming Tan; Yu Zheng; Liyang Gu; Li Guo; Fangfang Sun; Haiting Wang; Jiajie Li; Xiaodong Wang; Gabriela Riemekasten; Shuang Ye

doi:10.1093/rheumatology/key425

Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341)

Kaiwen Wang, Jiangfeng Zhao, Zhiwei Chen, Ting Li, Xiaoming Tan, Yu Zheng, Liyang Gu, Li Guo, Fangfang Sun, Haiting Wang, Jiajie Li, Xiaodong Wang, Gabriela Riemekasten, Shuang Ye^*

^*Korrespondierende/r Autor/-in für diese Arbeit

Klinik für Rheumatologie und klinische Immunologie

Renji Hospital

3 Zitate (Scopus)

Abstract

In the original article, corresponding author Shuang Ye's correspondence address listed the incorrect department. It should have read 'Department of Rheumatology'. This has now been corrected.

Originalsprache	Englisch
Zeitschrift	Rheumatology (United Kingdom)
Jahrgang	58
Ausgabenummer	3
Seiten (von - bis)	557
Seitenumfang	1
ISSN	1462-0324
DOIs	https://doi.org/10.1093/rheumatology/key425
Publikationsstatus	Veröffentlicht - 01.03.2019

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

Forschungsschwerpunkt: Infektion und Entzündung - Zentrum für Infektions- und Entzündungsforschung Lübeck (ZIEL)

Dokumente

10.1093/rheumatology/key425

Weitere Links

Link to publication in Scopus

Fingerprint

Untersuchen Sie die Forschungsthemen von „Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341)“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren

Wang, K., Zhao, J., Chen, Z., Li, T., Tan, X., Zheng, Y., Gu, L., Guo, L., Sun, F., Wang, H., Li, J., Wang, X., Riemekasten, G., & Ye, S. (2019). Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341). Rheumatology (United Kingdom), 58(3), 557. https://doi.org/10.1093/rheumatology/key425

@article{436babc1b88c47b6b2cd6858364a999c,

title = "Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341)",

abstract = "In the original article, corresponding author Shuang Ye's correspondence address listed the incorrect department. It should have read 'Department of Rheumatology'. This has now been corrected.",

author = "Kaiwen Wang and Jiangfeng Zhao and Zhiwei Chen and Ting Li and Xiaoming Tan and Yu Zheng and Liyang Gu and Li Guo and Fangfang Sun and Haiting Wang and Jiajie Li and Xiaodong Wang and Gabriela Riemekasten and Shuang Ye",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.",

year = "2019",

month = mar,

day = "1",

doi = "10.1093/rheumatology/key425",

language = "English",

volume = "58",

pages = "557",

journal = "Rheumatology (United Kingdom)",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "3",

}

Wang, K, Zhao, J, Chen, Z, Li, T, Tan, X, Zheng, Y, Gu, L, Guo, L, Sun, F, Wang, H, Li, J, Wang, X, Riemekasten, G & Ye, S 2019, 'Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341)', Rheumatology (United Kingdom), Jg. 58, Nr. 3, S. 557. https://doi.org/10.1093/rheumatology/key425

Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341). / Wang, Kaiwen; Zhao, Jiangfeng; Chen, Zhiwei et al.
in: Rheumatology (United Kingdom), Jahrgang 58, Nr. 3, 01.03.2019, S. 557.

Publikation: Beiträge in Fachzeitschriften › Kommentare/Debatten

TY - JOUR

T1 - Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341)

AU - Wang, Kaiwen

AU - Zhao, Jiangfeng

AU - Chen, Zhiwei

AU - Li, Ting

AU - Tan, Xiaoming

AU - Zheng, Yu

AU - Gu, Liyang

AU - Guo, Li

AU - Sun, Fangfang

AU - Wang, Haiting

AU - Li, Jiajie

AU - Wang, Xiaodong

AU - Riemekasten, Gabriela

AU - Ye, Shuang

N1 - Publisher Copyright: © The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.

PY - 2019/3/1

Y1 - 2019/3/1

N2 - In the original article, corresponding author Shuang Ye's correspondence address listed the incorrect department. It should have read 'Department of Rheumatology'. This has now been corrected.

AB - In the original article, corresponding author Shuang Ye's correspondence address listed the incorrect department. It should have read 'Department of Rheumatology'. This has now been corrected.

UR - https://www.scopus.com/pages/publications/85062525011

U2 - 10.1093/rheumatology/key425

DO - 10.1093/rheumatology/key425

M3 - Comments/Debates

C2 - 30590756

AN - SCOPUS:85062525011

SN - 1462-0324

VL - 58

SP - 557

JO - Rheumatology (United Kingdom)

JF - Rheumatology (United Kingdom)

IS - 3

ER -

Wang K, Zhao J, Chen Z, Li T, Tan X, Zheng Y et al. Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341). Rheumatology (United Kingdom). 2019 Mär 1;58(3):557. doi: 10.1093/rheumatology/key425